Učitavanje...
Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
Dual bronchodilation with long-acting beta-2 agonists and muscarinic antagonists is recommended in patients with severe to very severe COPD. Among dual bronchodilator combinations, indacaterol/glycopyrronium combination (IGC) received evidence of higher efficacy and good safety compared with monothe...
Spremljeno u:
| Izdano u: | Patient Prefer Adherence |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6338236/ https://ncbi.nlm.nih.gov/pubmed/30679906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S166704 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|